Disease | sleep apnea |
Phenotype | C0018802|congestive heart failure |
Sentences | 9 |
PubMedID- 21393364 | Complex sleep apnoea in congestive heart failure. |
PubMedID- 25211247 | Summary: as an adjunct to optimal pharmacological management, adaptive servo-ventilation shows considerable promise as a means to improve outcomes in patients with congestive heart failure complicated by central sleep apnea/hunter-cheyne-stokes breathing. |
PubMedID- 20953852 | sleep apnea in congestive heart failure. |
PubMedID- 24293994 | This was done to remove the possible confounding effect of sleep apnea.14 those with diagnoses of congestive heart failure, obstructive sleep apnea, chronic respiratory conditions other than copd, age <35 years, any disease limiting life expectancy to less than 2 years, active malignancy other than nonmelanotic skin cancer in the previous 2 years, and with any anatomic variation or disease process that precluded wearing a nasal mask were excluded. |
PubMedID- 23157523 | Increased mortality risk in congestive heart failure patients with comorbid sleep apnoea: 10-year follow up. |
PubMedID- 20505800 | Csas is a form of sleep apnoea in congestive heart failure which is driven by changes in pco(2). |
PubMedID- 26074186 | Central sleep apnoea in congestive heart failure. |
PubMedID- 25410846 | Theefficacy of asv has been established especially in the treatment of central sleep apneasyndrome associated with congestive heart failure. |
PubMedID- 21886358 | Study objectives: sleep apnea is common in patients with congestive heart failure, and may contribute to the progression of underlying heart disease. |
Page: 1